Abstract
For centuries, opioid drugs have been the mainstay of chronic pain treatment. However, over time analgesic tolerance develops, leaving few treatment options. Here we show that platelet-derived growth factor receptor-β2 (PDGFR-β2)-mediated signaling plays a key role in morphine tolerance. PDGFR-β2 inhibition selectively eliminates morphine tolerance in rats. PDGFR-β2 inhibitors are widely used and well tolerated, suggesting that clinical translation of our findings could reduce the suffering endured by individuals with intractable pain.
Original language | English (US) |
---|---|
Pages (from-to) | 385-387 |
Number of pages | 3 |
Journal | Nature medicine |
Volume | 18 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2012 |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology